Biologics
Takara Bio Expands Spatial Genomics Portfolio with Curio Bioscience Acquisition
Takara Bio USA Holdings, announced the acquisition of Curio Bioscience, a pioneering company in the field of spatial genomics. This strategic acquisition c...
January 16, 2025 | News
ImmunityBio Advances Marketing Authorization Applications for BCG-Unresponsive NMIBC CIS in Europe and the UK
Marketing authorization application for BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) with Carcinoma in situ (CIS) submitted to Europ...
January 16, 2025 | News
Lyndra Partners with Thermo Fisher to Drive Phase 3 Trials and Commercial Manufacturing of Long-Acting Oral Therapies
Leveraging its Accelerator™ Drug Development, 360° CDMO and CMO solutions, Thermo Fisher will provide clinical research services for Lyndra...
January 16, 2025 | News
Iconovo and Lonza Join Forces to Develop Intranasal Biologic for Obesity Treatment
Lonza to develop spray-dried formulations for an intranasally-delivered biologic for Iconovo at its Center of Excellence for bioavailability enhancemen...
January 15, 2025 | News
Advanced Genomics APAC and Cancer Precision Medicine Partner to Launch GALEAS™ Bladder Cancer Screening Test in Japan
Advanced Genomics APAC Co., Ltd. (hereinafter referred to as "Advanced Genomics APAC," headquartered in Taiwan, Managing Director: Andy Chang) i...
January 14, 2025 | News
CARsgen Therapeutics Administers First Dose of Allogeneic CAR T-Cell Therapy KJ-C2219 in Investigator-Initiated Trial
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignan...
January 14, 2025 | News
Simcere Zaiming and AbbVie Partner to Advance Novel Trispecific Antibody for Multiple Myeloma Treatment
Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) and AbbVie Inc. (NYSE: ABBV) today announced an option to license agreement ...
January 14, 2025 | News
Telix Pharmaceuticals Acquires ImaginAb’s Biologics Platform and Therapeutics Pipeline to Advance Precision Radiopharmaceuticals
Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, "Telix" or "the Company") today announced the acquisition of a next-generation therapeutics pipeline ...
January 13, 2025 | News
Complete Genomics Strengthens U.S. Manufacturing Footprint and Expands NGS Capabilities Amid Strategic Collaborations and Innovations
Complete Genomics, a pioneering genomic sequencing company, expanded its U.S. manufacturing footprint with augmented technology capabilities to diversify i...
January 13, 2025 | News
SN BioScience Secures FDA IND Clearance for SNB-101 Phase 1b/2 Trial, Targeting Extensive Stage Small Cell Lung Cancer
SN BioScience announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administra...
January 13, 2025 | News
Sciwind Biosciences Partners with Verdiva Bio in $2.4 Billion Deal to Advance Global Metabolic Disease Therapies
Hangzhou Sciwind Biosciences Co., a pre-commercial biopharmaceutical company focusing on developing innovative therapies to treat metabolic diseases, ...
January 13, 2025 | News
JW Therapeutics' Carteyva® Secures Breakthrough Therapy Designation in China for Relapsed/Refractory Large B-Cell Lymphoma
W Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focused on developing, manufacturing and commercializing ce...
January 13, 2025 | News
Kelun-Biotech and Harbour BioMed Ink $970 Million Licensing Deal with Windward Bio for Anti-TSLP Antibody
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company and HBM Holdings Limited ("Harbour BioMed") (togeth...
January 13, 2025 | News
Global Frenzy for TCE Bispecific Antibodies: Billion-Dollar Deals Propel Chinese Biotech to the Forefront
The trading of TCE (T Cell Engager) bispecific antibodies remains hot, and multinational pharmaceutical companies (MNCs) are still placing orders frantical...
January 10, 2025 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
